PolyMedix Message Board - Msg: 26525203

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PolyMedix

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: tnsaf	5/10/2010 12:29:48 PM
	of 77

May 10, 2010 11:01 UTC PolyMedix to Present at the Rodman and Renshaw Annual Global Investment Conference Rodman & Renshaw Annual Global Investment Conference 2010 RADNOR, Pa.--(BUSINESS WIRE)-- PolyMedix, Inc. (OTC BB: PYMX), an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, will be presenting at the Rodman & Renshaw Annual Global Investment Conference. The Conference will take place May 16 – 18, 2010 at the Grosvenor House Hotel in London, UK. Nicholas Landekic, President & CEO of PolyMedix will present on Monday, May 17, 2010 at 11:05 AM BST (6:05 AM ET). The presentation will be webcast live and may be accessed at wsw.com or on the Company’s website at polymedix.com. A replay will be available on both sites for ninety days.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next